How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic Literature Review
Crossref DOI link: https://doi.org/10.1007/s40120-021-00264-1
Published Online: 2021-07-19
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wiyani, Anggie http://orcid.org/0000-0002-5203-9797
Badgujar, Lohit
Khurana, Vivek
Adlard, Nicholas
Funding for this research was provided by:
Novartis Pharma AG
Text and Data Mining valid from 2021-07-19
Version of Record valid from 2021-07-19
Article History
Received: 2 June 2021
Accepted: 6 July 2021
First Online: 19 July 2021